These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 31897182)

  • 1. Overexpression of miR-106a enhances oxaliplatin sensitivity of colorectal cancer through regulation of FOXQ1.
    Liu Z; Qin Y; Dong S; Chen X; Huo Z; Zhen Z
    Oncol Lett; 2020 Jan; 19(1):663-670. PubMed ID: 31897182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-106a Reduces 5-Fluorouracil (5-FU) Sensitivity of Colorectal Cancer by Targeting Dual-Specificity Phosphatases 2 (DUSP2).
    Qin Y; Chen X; Liu Z; Tian X; Huo Z
    Med Sci Monit; 2018 Jul; 24():4944-4951. PubMed ID: 30011263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FOXQ1 mediates the crosstalk between TGF-β and Wnt signaling pathways in the progression of colorectal cancer.
    Peng X; Luo Z; Kang Q; Deng D; Wang Q; Peng H; Wang S; Wei Z
    Cancer Biol Ther; 2015; 16(7):1099-109. PubMed ID: 25955104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of forkhead box Q1 by microRNA-506 represses the proliferation and epithelial-mesenchymal transition of cervical cancer cells.
    Zhang M; Xu Q; Yan S; Li Z; Yan W; Jia X
    Oncol Rep; 2016 May; 35(5):3106-14. PubMed ID: 26935526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [miRNA-96-5p inhibits the proliferation and migration of gastric cancer cells by targeting FoxQ1].
    Yang XY; Li N; Deng WY; Ma YJ; Han XL; Zhang ZY; Xie JL; Luo SX
    Zhonghua Zhong Liu Za Zhi; 2019 Mar; 41(3):193-199. PubMed ID: 30917455
    [No Abstract]   [Full Text] [Related]  

  • 6. Biological effects and clinical characteristics of microRNA-106a in human colorectal cancer.
    He Y; Wang G; Zhang L; Zhai C; Zhang J; Zhao X; Jiang X; Zhao Z
    Oncol Lett; 2017 Jul; 14(1):830-836. PubMed ID: 28693239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-106a-5p promotes 5-FU resistance and the metastasis of colorectal cancer by targeting TGFβR2.
    Liu J; Huang Y; Wang H; Wu D
    Int J Clin Exp Pathol; 2018; 11(12):5622-5634. PubMed ID: 31949649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-937 inhibits the malignant phenotypes of breast cancer by directly targeting and downregulating forkhead box Q1.
    Han X; Guo X; Zhang W; Cong Q
    Onco Targets Ther; 2019; 12():4813-4824. PubMed ID: 31417280
    [No Abstract]   [Full Text] [Related]  

  • 9. MicroRNA-320 suppresses colorectal cancer by targeting SOX4, FOXM1, and FOXQ1.
    Vishnubalaji R; Hamam R; Yue S; Al-Obeed O; Kassem M; Liu FF; Aldahmash A; Alajez NM
    Oncotarget; 2016 Jun; 7(24):35789-35802. PubMed ID: 27119506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-106a-3p Induces Apatinib Resistance and Activates Janus-Activated Kinase 2 (JAK2)/Signal Transducer and Activator of Transcription 3 (STAT3) by Targeting the SOCS System in Gastric Cancer.
    Guo W; Li W; Yuan L; Mei X; Hu W
    Med Sci Monit; 2019 Dec; 25():10122-10128. PubMed ID: 31884511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-519 inhibits epithelial-mesenchymal transition and biologic behavior of gastric cancer cells by down-regulating FOXQ1.
    Xu J; You Q; Wei Z; Fu H; Zhang Y; Hu Z; Cai Q
    Int J Clin Exp Pathol; 2020; 13(3):425-436. PubMed ID: 32269679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of miR-96 enhances the sensitivity of colorectal cancer cells to oxaliplatin by targeting TPM1.
    Ge T; Xiang P; Mao H; Tang S; Zhou J; Zhang Y
    Exp Ther Med; 2020 Sep; 20(3):2134-2140. PubMed ID: 32765688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FOXQ1 is overexpressed in colorectal cancer and enhances tumorigenicity and tumor growth.
    Kaneda H; Arao T; Tanaka K; Tamura D; Aomatsu K; Kudo K; Sakai K; De Velasco MA; Matsumoto K; Fujita Y; Yamada Y; Tsurutani J; Okamoto I; Nakagawa K; Nishio K
    Cancer Res; 2010 Mar; 70(5):2053-63. PubMed ID: 20145154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-106a Increases Granulosa Cell Viability and Is Downregulated in Women With Diminished Ovarian Reserve.
    Hong L; Peng S; Li Y; Fang Y; Wang Q; Klausen C; Yin C; Wang S; Leung PCK; Yang X
    J Clin Endocrinol Metab; 2018 Jun; 103(6):2157-2166. PubMed ID: 29590425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. microRNA-106a modulates cisplatin sensitivity by targeting PDCD4 in human ovarian cancer cells.
    Li H; Xu H; Shen H; Li H
    Oncol Lett; 2014 Jan; 7(1):183-188. PubMed ID: 24348845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-1271 Inhibits Cell Proliferation, Invasion and EMT in Gastric Cancer by Targeting FOXQ1.
    Xiang XJ; Deng J; Liu YW; Wan LY; Feng M; Chen J; Xiong JP
    Cell Physiol Biochem; 2015; 36(4):1382-94. PubMed ID: 26159618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-106a suppresses tumor cells death in colorectal cancer through targeting ATG7.
    Hao H; Xia G; Wang C; Zhong F; Liu L; Zhang D
    Med Mol Morphol; 2017 Jun; 50(2):76-85. PubMed ID: 27981410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FOXQ1 is overexpressed in laryngeal carcinoma and affects cell growth, cell cycle progression and cell invasion.
    Zhang J; Li W; Dai S; Tai X; Jia J; Guo X
    Oncol Lett; 2015 Oct; 10(4):2499-2504. PubMed ID: 26622879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-122 enhances sensitivity of hepatocellular carcinoma to oxaliplatin via inhibiting MDR1 by targeting Wnt/β-catenin pathway.
    Cao F; Yin LX
    Exp Mol Pathol; 2019 Feb; 106():34-43. PubMed ID: 30539797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-106a-mediated malignant transformation of cells induced by anti-benzo[a]pyrene-trans-7,8-diol-9,10-epoxide.
    Jiang Y; Wu Y; Greenlee AR; Wu J; Han Z; Li X; Zhao Y
    Toxicol Sci; 2011 Jan; 119(1):50-60. PubMed ID: 20889678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.